Variant report
Variant | nsv1063642 |
---|---|
Chromosome Location | chr16:77169206-77194119 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MON1B-2 | chr16:77183322-77183751 | NONHSAT143790 |
2 | lnc-MON1B-2 | chr16:77183883-77185106 | NONHSAT143790 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000188825 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567040640 | chr16:77170811-77170812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535918176 | chr16:77170820-77170821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375525275 | chr16:77170838-77170839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs386792334 | chr16:77170847-77170848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs55833064 | chr16:77170848-77170849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs12051225 | chr16:77170866-77170867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs558859865 | chr16:77170878-77170879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369993362 | chr16:77170902-77170903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575403106 | chr16:77170915-77170916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115289757 | chr16:77170951-77170952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188478892 | chr16:77170957-77170958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547253471 | chr16:77170958-77170959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574060946 | chr16:77170993-77170994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567571393 | chr16:77170994-77170995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191814552 | chr16:77171021-77171022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71716588 | chr16:77171027-77171028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374590054 | chr16:77171068-77171069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559875302 | chr16:77171115-77171116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528728162 | chr16:77171163-77171164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551633859 | chr16:77171167-77171168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13330504 | chr16:77171183-77171184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536013305 | chr16:77171184-77171185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113624840 | chr16:77179013-77179014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533568974 | chr16:77179050-77179051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9939570 | chr16:77179052-77179053 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs9932469 | chr16:77179084-77179085 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs113758921 | chr16:77179115-77179116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187527680 | chr16:77179184-77179185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371906901 | chr16:77179203-77179204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549632112 | chr16:77179256-77179257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112525727 | chr16:77179264-77179265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9940339 | chr16:77179300-77179301 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs551063642 | chr16:77179303-77179304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369176172 | chr16:77179304-77179305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71378608 | chr16:77179333-77179334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12924113 | chr16:77179335-77179336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs146763781 | chr16:77179336-77179337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553224675 | chr16:77179346-77179347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9922157 | chr16:77179360-77179361 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs569477685 | chr16:77181992-77181993 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs186847078 | chr16:77182029-77182030 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs555248704 | chr16:77182086-77182087 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs76085604 | chr16:77182094-77182095 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs150537486 | chr16:77182111-77182112 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs553829827 | chr16:77182176-77182177 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576889527 | chr16:77182230-77182231 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs539581671 | chr16:77182246-77182247 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs71394299 | chr16:77182255-77182256 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs543285339 | chr16:77182287-77182288 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs541619859 | chr16:77182306-77182307 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20581869 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Melanoma | 17363583 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:77170800-77171200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr16:77179000-77179400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr16:77188600-77189000 | Enhancers | Fetal Stomach | stomach |
4 | chr16:77191000-77191200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr16:77191000-77191200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr16:77191200-77191400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr16:77191200-77191400 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr16:77191200-77191600 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr16:77191200-77192000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr16:77191400-77191800 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr16:77191600-77192000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr16:77191800-77192000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr16:77192000-77192200 | Enhancers | Fetal Muscle Leg | muscle |
14 | chr16:77192000-77192400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr16:77192000-77192600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |